Literature DB >> 1360022

Memory and naive CD4+ lymphocytes in multiple sclerosis.

A M Porrini1, D Gambi, G Malatesta.   

Abstract

Helper-inducer (CD29+CD4+) and suppressor-inducer (CD45RACD4+) T-cells have been recently renamed as memory and naive T-cells, respectively. We measured cells expressing these phenotypes in peripheral blood of 46 definite multiple sclerosis (MS) patients [32 relapsing-remitting (RR-MS), 14 secondary progressive (P-MS)] and controls. CD25+ (interleukin-2-receptor-positive) cells were also evaluated in the same groups of patients. RR-MS patients showed increased levels of CD29+CD4+ and CD25+ cells compared with controls. This finding was more evident in RR-MS patients during the attack than during the stable phase of the disease. In P-MS patients we found a reduction of CD45+CD4+ cells compared with either RR-MS patients or control subjects. Our results show that RR-MS and P-MS are characterized by two different T-cell subpopulations. This finding supports the hypothesis that during the evolution from RR-MS and P-MS changes occur in the immunological status of the patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360022     DOI: 10.1007/bf00856808

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  31 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  Phenotypic identification of memory cytolytic T lymphocytes in a subset of Lyt-2+ cells.

Authors:  R C Budd; J C Cerottini; H R MacDonald
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

3.  Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event.

Authors:  H M Serra; J F Krowka; J A Ledbetter; L M Pilarski
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

4.  Antibodies to common leukocyte antigen p220 influence human T cell proliferation by modifying IL 2 receptor expression.

Authors:  J A Ledbetter; L M Rose; C E Spooner; P G Beatty; P J Martin; E A Clark
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

5.  The isolation and characterization of the human helper inducer T cell subset.

Authors:  C Morimoto; N L Letvin; A W Boyd; M Hagan; H M Brown; M M Kornacki; S F Schlossman
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

6.  The 2H4 molecule but not the T3-receptor complex is involved in suppressor inducer signals in the AMLR system.

Authors:  T Takeuchi; S F Schlossman; C Morimoto
Journal:  Cell Immunol       Date:  1987-06       Impact factor: 4.868

7.  A rapid, no-wash technic for immunophenotypic analysis by flow cytometry.

Authors:  C W Caldwell; H M Taylor
Journal:  Am J Clin Pathol       Date:  1986-11       Impact factor: 2.493

8.  Decreased suppressor-inducer T lymphocytes in multiple sclerosis and other neurological diseases.

Authors:  C Rohowsky-Kochan; D Eiman; R Troiano; S Bansil; J Oleske; T Denny; S D Cook
Journal:  J Neuroimmunol       Date:  1990-07       Impact factor: 3.478

9.  Human lymphocyte differentiation antigens HB-10 and HB-11. II. Differential production of B cell growth and differentiation factors by distinct helper T cell subpopulations.

Authors:  T F Tedder; M D Cooper; L T Clement
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

10.  The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes.

Authors:  A S Bellamy; V L Calder; M Feldmann; A N Davison
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

View more
  6 in total

1.  Expression of CCR2, CCR5, and CXCR3 by CD4+ T cells is stable during a 2-year longitudinal study but varies widely between individuals.

Authors:  Pia Kivisäkk; Corinna Trebst; Jar-Chi Lee; Barbara H Tucky; Richard A Rudick; James J Campbell; Richard M Ransohoff
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

2.  Differences in systemic and central nervous system cellular immunity relevant to relapsing-remitting multiple sclerosis.

Authors:  Makoto Matsui; Shin-ichi Araya; Hui-Yun Wang; Kouji Matsushima; Takahiko Saida
Journal:  J Neurol       Date:  2005-03-21       Impact factor: 4.849

3.  Production of T-helper cell subsets and cytokines by lymphocytes from patients with chronic mucocutaneous candidiasis.

Authors:  L J Kobrynski; L Tanimune; L Kilpatrick; D E Campbell; S D Douglas
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

4.  CD4 subsets (CD45RA/RO) exhibit differences in proliferative responses, IL-2 and gamma-interferon production during intravenous methylprednisolone treatment of multiple sclerosis.

Authors:  A D Crockard; M T Treacy; A G Droogan; S A Hawkins
Journal:  J Neurol       Date:  1996-06       Impact factor: 4.849

5.  Alterations in levels of CD28-/CD8+ suppressor cell precursor and CD45RO+/CD4+ memory T lymphocytes in the peripheral blood of multiple sclerosis patients.

Authors:  B Crucian; P Dunne; H Friedman; R Ragsdale; S Pross; R Widen
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

6.  Alterations in peripheral blood mononuclear cell cytokine production in response to phytohemagglutinin in multiple sclerosis patients.

Authors:  B Crucian; P Dunne; H Friedman; R Ragsdale; S Pross; R Widen
Journal:  Clin Diagn Lab Immunol       Date:  1995-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.